TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
←

georgi ganev

T2 · manager / operator

CEO of Kinnevik, a Swedish publicly listed investment company founded in 1936 with founding family ownership, focused on backing novel business models in healthcare, consumer, and technology with a multi-generational time horizon.

4 calls·4 names·50% bull·last heard 2 years ago·In Good Company with Nicolai Tangen
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$SOLUGENSolugenposition

Kinnevik backs Solugen's carbon-negative chemical engineering platform, impossible 5-10 years ago

Solugen has reinvented chemical engineering to produce materials that are carbon net negative, a breakthrough impossible just 5-10 years ago, representing the translation of biology into technology that removes previous boundaries.

In Good Company with Nicolai Tangen2024-09episode →
2ndhigh conviction
$RXRXRecursion Pharmaceuticalsposition

Kinnevik backs Recursion's drug discovery platform over pipeline candidates, betting on structural transformation

Kinnevik invests in Recursion's platform capability to fundamentally change drug discovery success rates over the long term, rather than focusing on near-term pipeline milestones like phase transitions that drive short-term investor attention.

In Good Company with Nicolai Tangen2024-09episode →
3rdmedium conviction
$SPOTSpotify

Spotify proves Europe can produce global winners but ambition gap with US persists

Spotify demonstrates European companies can become global category leaders, yet the broader European ecosystem still lacks the ambition level seen in US founders and investors who pursue 'impossible' outcomes rather than regulatory boundaries.

In Good Company with Nicolai Tangen2024-09episode →

most discussed · click a bar to filter

  • $SPOT
  • $NVDA
  • $SOLUGEN
  • $RXRX

recurring themes

  • Public Markets & Valuation1
  • Geopolitics & Trade1
  • Venture Capital1
4 total
$SPOT
···
Spotify
MEDgeorgi ganev·In Good Company with Nicolai Tangen·2 years ago·Kinnevik CEO Georgi Ganev and Chair James Anderson | Norges Bank Investment Management
Spotify proves Europe can produce global winners but ambition gap with US persists
Spotify demonstrates European companies can become global category leaders, yet the broader European ecosystem still lacks the ambition level seen in US founders and investors who pursue 'impossible' outcomes rather than regulatory boundaries.
"companies like Spotify and others that have proven that you can truly become Global winners but still I think the ambition level is is a big difference"
22:13
$NVDA
···
Nvidia
MEDgeorgi ganev·In Good Company with Nicolai Tangen·2 years ago·Kinnevik CEO Georgi Ganev and Chair James Anderson | Norges Bank Investment Management
Nvidia's 2006 80% share drop from R&D investment created trillion-dollar platform, markets punish long-term bets
Nvidia's near-collapse in 2006 when share price dropped over 80% was caused by heavy R&D investment in a platform that later created a trillion-dollar company, illustrating how public markets fail to reward long-term innovation.
"Nvidia H when they had this massive uh setback in I think it was 2006 and then nearly they were nearly wiped out right exactly share price dropped more than 8% and and the sad thi…"
25:30
$SOLUGEN
Solugen
HIGHgeorgi ganev·In Good Company with Nicolai Tangen·2 years ago·Kinnevik CEO Georgi Ganev and Chair James Anderson | Norges Bank Investment Management· position
Kinnevik backs Solugen's carbon-negative chemical engineering platform, impossible 5-10 years ago
Solugen has reinvented chemical engineering to produce materials that are carbon net negative, a breakthrough impossible just 5-10 years ago, representing the translation of biology into technology that removes previous boundaries.
"we backed a fantastic company called Solen in the US that has reinvented chemical engineering they can actually produce materials um and the result is kind of carbon net negative…"
29:05
$RXRX
···
Recursion Pharmaceuticals
HIGHgeorgi ganev·In Good Company with Nicolai Tangen·2 years ago·Kinnevik CEO Georgi Ganev and Chair James Anderson | Norges Bank Investment Management· position
Kinnevik backs Recursion's drug discovery platform over pipeline candidates, betting on structural transformation
Kinnevik invests in Recursion's platform capability to fundamentally change drug discovery success rates over the long term, rather than focusing on near-term pipeline milestones like phase transitions that drive short-term investor attention.
"we can look at companies in our portfolios today like recursion for instance where we as an investor would back the platform of drug Discovery whereas many investors today they wo…"
7:43
8
Public Markets & Valuationheadwind
Public markets systematically punish long-term R&D investment, creating advantage for patient private capital
Public market short-termism forces companies to optimize for quarterly results over decade-scale R&D (exemplified by Nvidia's 2006 near-death), giving private and permanent capital structures a structural advantage in funding transformative innovation.
7
Geopolitics & Tradeheadwind
European tech ecosystem suffers from ambition deficit versus US, not capability gap
Europe's startup disadvantage stems from lower ambition levels among both founders and investors—focused on regulatory boundaries rather than impossible outcomes—compounded by fragmented markets requiring early internationalization, not from lack of talent or infrastructure.
7
Venture Capitaltailwind
Private market structures enable long-term company building that public markets disrupt
Private company founders retain freedom to invest in multi-year innovation without daily share price pressure, while public listing introduces short-term evaluation metrics that conflict with the time horizons required for breakthrough R&D.